Related Experiment Video

Updated: May 20, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Comorbidities and the quality of life in hypertensive patients

Monika Zygmuntowicz1, Aleksander Owczarek, Adam Elibol

  • 1Pathophysiology Unit, Department of Pathophysiology, Medical University of Silesia, Katowice, Poland.

Polskie Archiwum Medycyny Wewnetrznej
|July 21, 2012
PubMed

Insights

Comorbidities significantly reduce health-related quality of life (HRQoL) in hypertensive patients. Conditions like heart failure, stroke, and diabetes markedly lower HRQoL, underscoring the impact of chronic diseases.

Area of Science:

  • Cardiology
  • Public Health
  • General Medicine

Background:

  • Health-related quality of life (HRQoL) is crucial for patients with chronic conditions.
  • Polymorbidity significantly impacts perceived HRQoL.
  • The influence of concurrent chronic diseases on hypertensive patients' HRQoL remains under-researched.

Purpose of the Study:

  • To investigate the association between comorbidities and various HRQoL aspects in a large, unselected hypertensive patient cohort.
  • To identify specific comorbidities that most significantly affect HRQoL in hypertension.
  • To analyze demographic and therapeutic factors influencing HRQoL in this population.

Main Methods:

  • A questionnaire-based study involving 12,525 hypertensive patients treated for at least 3 months.
  • Data collected by 832 primary care physicians.
  • HRQoL assessed using the Medical Outcomes Study 12-item Short-Form Health Survey (SF-12).

Main Results:

  • 63.8% of patients had coexisting diseases, negatively impacting HRQoL.
  • Obstructive respiratory disease, cardiovascular diseases (CAD, heart failure, stroke), diabetes, and mood disorders were strongly associated with lower HRQoL.
  • HRQoL decreased with age and longer antihypertensive therapy duration; higher education and male sex were associated with better HRQoL.

Conclusions:

  • Concurrent chronic diseases significantly diminish all dimensions of HRQoL in hypertensive patients.
  • Specific comorbidities like cardiovascular and metabolic diseases have a profound negative effect.
  • Addressing comorbidities is essential for improving the overall well-being of hypertensive individuals.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...